EAGLE PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was $10.3M, a 368% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was $41M, a 29% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was $81M, a 2824% increase from 2021.
  • Eagle Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was $2.77M, a 91.6% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was $33M, a 51.1% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $41M $10.3M +$8.1M +368% Apr 1, 2023 Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 $32.9M $11.8M -$48.1M -80.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $81M $9.47M +$3.57M +60.5% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-23
Q3 2022 $77.4M $9.46M +$19.6M Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $57.8M $2.2M -$8.62M -79.6% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-08-09
Q1 2022 $66.4M $59.8M +$63.6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $2.77M $5.9M -$3.89M -39.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $6.66M -$10.2M -$25.6M -166% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $32.3M $10.8M +$7.11M +192% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $25.1M -$3.77M -$7.81M -194% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $33M $9.79M +$6.9M +238% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $26.1M $15.4M +$17.9M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $8.16M $3.71M -$5.52M -59.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $13.7M $4.04M -$8.13M -66.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $21.8M $2.9M -$12.8M -81.6% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-02
Q3 2019 $34.6M -$2.48M -$20.9M -113% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $55.5M $9.23M +$9.05M +4945% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $46.5M $12.2M +$9.86M +428% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $36.6M $15.7M +$5.28M +50.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 $31.3M $18.4M -$6.55M -26.2% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 $37.9M $183K -$5.72M -96.9% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 $43.6M $2.31M -$30.4M -93% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 $74M $10.4M -$17.8M -63.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $91.8M $25M +$12.6M +103% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 $79.2M $5.9M -$7.75M -56.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 $86.9M $32.7M +$33.6M Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 $53.4M $28.3M +$27.1M +2271% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-26
Q3 2016 $26.3M $12.3M +$22.7M Jul 1, 2016 Sep 30, 2016 10-K 2018-02-26
Q2 2016 $3.56M $13.7M +$22M Apr 1, 2016 Jun 30, 2016 10-K 2018-02-26
Q1 2016 -$18.4M -$897K -$21M -104% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-26
Q4 2015 $2.56M $1.19M +$7.76M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$5.2M -$10.4M -$1.28M -14.1% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$3.92M -$8.34M -$5.35M -180% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 $1.44M $20.1M +$23.7M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$22.3M -$6.57M -$3.5M -114% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$18.8M -$9.11M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$2.98M -$4.24M -337% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$3.6M +$703K +16.3% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$3.07M Oct 1, 2013 Dec 31, 2013 10-K 2017-03-15
Q2 2013 $1.26M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$4.31M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.